VERA - Vera Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERA is currently covered by 7 analysts with an average price target of $45.19. This is a potential upside of $23.9 (112.26%) from yesterday's end of day stock price of $21.29.

Vera Therapeutics's activity chart (see below) currently has 13 price targets and 42 ratings on display. The stock rating distribution of VERA is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.39% with an average time for these price targets to be met of 143.5 days.

Highest price target for VERA is $107, Lowest price target is $38, average price target is $63.57.

Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 04-Mar-2025. First documented stock forecast 08-Jun-2021.

Currently out of the existing stock ratings of VERA, 28 are a BUY (87.5%), 4 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$71

$48.57 (216.54%)

$75

1 months 14 days ago
(04-Mar-2025)

5/11 (45.45%)

$42.59 (149.91%)

271

Buy

$61

$38.57 (171.96%)

$64

1 months 22 days ago
(27-Feb-2025)

1/5 (20%)

$31.59 (107.41%)

163

Hold

$38

$15.57 (69.42%)

$34

5 months 10 days ago
(08-Nov-2024)

7/7 (100%)

$-10.09 (-20.98%)

189

Buy

$75

$52.57 (234.37%)

$20

5 months 21 days ago
(28-Oct-2024)

3/4 (75%)

$27.66 (58.43%)

252

Buy

$107

$84.57 (377.04%)

$107

6 months 17 days ago
(01-Oct-2024)

0/4 (0%)

$64.17 (149.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERA (Vera Therapeutics) average time for price targets to be met?

On average it took 143.5 days on average for the stock forecasts to be realized with a an average price target met ratio 63.39

Which analyst has the current highest performing score on VERA (Vera Therapeutics) with a proven track record?

LIISA BAYKO

Which analyst has the current lower performing score on VERA (Vera Therapeutics) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on VERA (Vera Therapeutics)?

Liisa Bayko works at EVERCORE and has 6 price targets and 5 ratings on VERA

Which analyst is the currently most bullish on VERA (Vera Therapeutics)?

Pete Stavropoulos with highest potential upside - $84.57

Which analyst is the currently most reserved on VERA (Vera Therapeutics)?

Maury Raycroft with lowest potential downside - -$21.46

Vera Therapeutics in the News

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on April 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 211,250 shares of Class A common stock and restricted stock units (RSUs) for 105,125 shares of Class A common stock to sixteen...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?